Does SIPONIMOD Cause Basal cell carcinoma? 102 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Basal cell carcinoma have been filed in association with SIPONIMOD (MAYZENT). This represents 1.2% of all adverse event reports for SIPONIMOD.
102
Reports of Basal cell carcinoma with SIPONIMOD
1.2%
of all SIPONIMOD reports
0
Deaths
6
Hospitalizations
How Dangerous Is Basal cell carcinoma From SIPONIMOD?
Of the 102 reports, 6 (5.9%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIPONIMOD. However, 102 reports have been filed with the FAERS database.
What Other Side Effects Does SIPONIMOD Cause?
Fatigue (958)
Headache (862)
Dizziness (654)
Gait disturbance (506)
Multiple sclerosis relapse (504)
Fall (478)
Multiple sclerosis (455)
Lymphocyte count decreased (398)
Nausea (397)
Drug ineffective (396)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which SIPONIMOD Alternatives Have Lower Basal cell carcinoma Risk?
SIPONIMOD vs SIPULEUCEL-T
SIPONIMOD vs SIROLIMUS
SIPONIMOD vs SIRUKUMAB
SIPONIMOD vs SITAGLIPTIN
SIPONIMOD vs SKYLA